Seelos Therapeutics, Inc. (NXE.F)
Frankfurt - Frankfurt Delayed Price. Currency in USD
Add to watchlist
As of 09:09AM CEST. Market open.
| Previous Close | 3.3720 |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | N/A - N/A |
| 52 Week Range | 2.0000 - 345.8400 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 0 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Insider Spends US$100k Buying More Shares In Seelos Therapeutics
Investors who take an interest in Seelos Therapeutics, Inc. ( NASDAQ:SEEL ) should definitely note that the Chief...
- GuruFocus.com
Insider Buying: CFO Michael Golembiewski Acquires 83,000 Shares of Seelos Therapeutics Inc (SEEL)
In the realm of stock market movements, insider trading can provide valuable insights into a company's health and future prospects.
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Leafly challenged and triumphed against New York’s marijuana advertisement restrictions. Columbia Care rebranded as The Cannabist Co. and secured $25 million in private placement. Canopy Growth raised $25 million in a private placement offering. Key Takeaways; Psychedelic Sector Awakn’s CRO, Prof. David Nutt, delivered keynote at The Clinic of Change event. […]
© 2024 Yahoo. All rights reserved.